Connect Biopharma (CNTB) Institutional Ownership → Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad) Free CNTB Stock Alerts $1.96 +0.32 (+19.51%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$2.45MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$231.25K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Ad The Oxford ClubAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years. See His Breakdown of the Seven Stocks You Should Own Here. Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036% 1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023 Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% 11/14/2022 Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022 DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022 Kynam Capital Management LP227,759$688K0.2%N/A0.414% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/22/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022 Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022 Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022 Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021 Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021 Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021 BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021 Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021 Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021 Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021 RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021 Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021 FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021 BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021 Citigroup Inc.1,413$28K0.0%N/A0.002% 5/19/2021 Logos Global Management LP150,000$2.78M0.3%N/A0.261% 5/19/2021 Octagon Capital Advisors LP373,492$6.91M2.6%N/A0.650% 5/18/2021 Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021 Zimmer Partners LP10,000$185K0.0%N/A0.017% 5/18/2021 RA Capital Management L.P.2,991,208$55.34M0.8%N/A5.202% 5/18/2021 State of Wisconsin Investment Board100,272$1.86M0.0%N/A0.174% 5/18/2021 Alyeska Investment Group L.P.50,000$925K0.0%N/A0.087% 5/18/2021 Boxer Capital LLC2,081,323$38.50M1.3%N/A3.619% 5/18/2021 Cormorant Asset Management LP1,000,000$18.50M0.4%N/A1.739% 5/18/2021 Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% 5/17/2021 Point72 Hong Kong Ltd10,426$193K0.0%N/A0.018% 5/17/2021 Rock Springs Capital Management LP119,114$2.20M0.0%N/A0.207% 5/17/2021 DAFNA Capital Management LLC8,000$148K0.0%N/A0.014% 5/17/2021 Janus Henderson Group PLC475,000$8.70M0.0%N/A0.826% 5/17/2021Pinz Capital Management LP43,100$797K0.2%N/A0.075% 5/17/2021 Sphera Funds Management LTD.50,000$925K0.1%N/A0.087% No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY5/14/2021 RTW Investments LP450,000$8.33M0.1%N/A0.783% 5/14/2021 Monashee Investment Management LLC110,000$2.04M0.3%N/A0.191% 5/13/2021 Federated Hermes Inc.40,000$740K0.0%N/A0.070% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Connect Biopharma shares: BML Capital Management LLC ($2.43M), Kynam Capital Management LP ($603K), DAFNA Capital Management LLC ($218K), and Boothbay Fund Management LLC ($35K), Keudell Morrison Wealth Management ($34K).Learn more on CNTB's institutional investors. What percentage of Connect Biopharma stock is owned by institutional investors? 58.72% of Connect Biopharma stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma stock? The following institutional investors have purchased Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($2.06M), DAFNA Capital Management LLC ($250K), and Keudell Morrison Wealth Management ($8.50K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 2,319,938 shares in the last 24 months. This purchase volume represents approximately $2.66M in transactions. Which Connect Biopharma major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: Kynam Capital Management LP ($204.64K), and Boothbay Fund Management LLC ($50.98K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 255,628 shares in the last 24 months. This volume of shares sold represents approximately $297.02K in transactions. Related Companies: RAPT Institutional Ownership ZVRA Institutional Ownership ORGO Institutional Ownership VRCA Institutional Ownership AMRN Institutional Ownership PGEN Institutional Ownership NLTX Institutional Ownership STTK Institutional Ownership VTYX Institutional Ownership NKTX Institutional Ownership This page (NASDAQ:CNTB) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.